Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03727594
What this trial is testing

Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
University Hospital of Ferrara 50
Not applicableWithdrawnNCT06276946
What this trial is testing

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Who this might be right for
Oropharynx CancerHead and Neck CancerXerostomia
UNC Lineberger Comprehensive Cancer Center
Not applicableStudy completedNCT04952922
What this trial is testing

Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer

Who this might be right for
Recurrent Oropharynx Carcinoma
Royal Marsden NHS Foundation Trust 25
Not applicableStudy completedNCT00019201
What this trial is testing

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00571974
What this trial is testing

Treatment of Oral Premalignant Lesions With 5-ALA PDT

Who this might be right for
LeukoplakiaErythroplakia
University of Arkansas 29
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT06947668
What this trial is testing

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Who this might be right for
Squamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of the HypopharynxLarynx Squamous Cell Carcinoma+1 more
University of Erlangen-Nürnberg Medical School 250
Not applicableActive Not RecruitingNCT05565313
What this trial is testing

Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI

Who this might be right for
Head and Neck Carcinoma
Maastricht Radiation Oncology 900
Not applicableStudy completedNCT04112940
What this trial is testing

Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study

Who this might be right for
Deglutition DisordersOropharynx Cancer
University Health Network, Toronto 12
Not applicableLooking for participantsNCT07548268
What this trial is testing

Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CarcinomaUltrasound
Tobias Todsen 180
Not applicableActive Not RecruitingNCT03210103
What this trial is testing

Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 61
Testing effectiveness (Phase 2)Ended earlyNCT03254927
What this trial is testing

CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT02225496
What this trial is testing

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Cancer
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT02784288
What this trial is testing

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Who this might be right for
Oropharyngeal Squamous Cell Cancer
University of Michigan Rogel Cancer Center 40
Not applicableLooking for participantsNCT05451303
What this trial is testing

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Who this might be right for
Oral Squamous Cell CarcinomaOropharynx Squamous Cell CarcinomaPremalignant Lesion
Viome 475
Early research (Phase 1)Study completedNCT00003430
What this trial is testing

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01173692
What this trial is testing

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

Who this might be right for
Oropharynx Cancer
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Ended earlyNCT04015336
What this trial is testing

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Who this might be right for
Papillomavirus InfectionsOropharyngeal Neoplasms
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Not applicableStudy completedNCT06730412
What this trial is testing

CtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 103
Next Page